Adynovate US patent expiry: November 2027 (Morgan Stanley) - Jun 24, 2021 - A subscription to REFINITIV is required to access document 92707563 | Page no: 39 | REPORT TITLE: "Healthcare credit research: The pharmaceutical pipeline: 2Q 2021 edition" | AUTHOR: Kyle Roland, et al | DATE: 06/09/21
Patent • Hemophilia
|
|
If you have access to Aftermarket Research from Refinitiv, please log in to your account using this link and enter report number or title to find the report. If you don’t have access but would like to purchase the report please contact OnDemand@refinitiv.com.
|